Concepts (75)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histiocytic Sarcoma | 1 | 2025 | 5 | 0.930 |
Why?
|
| Malacoplakia | 1 | 2025 | 4 | 0.910 |
Why?
|
| Genital Diseases, Male | 1 | 2025 | 13 | 0.910 |
Why?
|
| Scrotum | 1 | 2025 | 29 | 0.900 |
Why?
|
| Cell Transdifferentiation | 1 | 2025 | 58 | 0.880 |
Why?
|
| Tryptases | 2 | 2021 | 17 | 0.820 |
Why?
|
| Mast Cells | 2 | 2021 | 69 | 0.790 |
Why?
|
| Immunologic Deficiency Syndromes | 2 | 2021 | 209 | 0.770 |
Why?
|
| Multiple Myeloma | 1 | 2025 | 216 | 0.750 |
Why?
|
| Mastocytosis, Systemic | 1 | 2020 | 8 | 0.650 |
Why?
|
| Lung Transplantation | 1 | 2025 | 358 | 0.650 |
Why?
|
| Hypereosinophilic Syndrome | 1 | 2020 | 9 | 0.650 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 464 | 0.530 |
Why?
|
| Diet Therapy | 1 | 2017 | 41 | 0.520 |
Why?
|
| Leukemia | 1 | 2020 | 374 | 0.510 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2017 | 77 | 0.490 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2017 | 331 | 0.450 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2017 | 302 | 0.440 |
Why?
|
| Biomarkers | 1 | 2020 | 3365 | 0.330 |
Why?
|
| Diagnosis, Differential | 2 | 2025 | 1904 | 0.260 |
Why?
|
| Paget Disease, Extramammary | 1 | 2025 | 5 | 0.240 |
Why?
|
| Vulvar Neoplasms | 1 | 2025 | 21 | 0.240 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2025 | 62 | 0.230 |
Why?
|
| Anaphylaxis | 2 | 2023 | 91 | 0.220 |
Why?
|
| Lymphatic Metastasis | 1 | 2025 | 431 | 0.220 |
Why?
|
| Arthropod Venoms | 1 | 2023 | 7 | 0.210 |
Why?
|
| Ants | 1 | 2023 | 8 | 0.200 |
Why?
|
| Lymph Nodes | 1 | 2025 | 375 | 0.200 |
Why?
|
| Carcinoma, Renal Cell | 1 | 2025 | 239 | 0.200 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2025 | 138 | 0.200 |
Why?
|
| Immunosuppressive Agents | 2 | 2025 | 671 | 0.200 |
Why?
|
| Insect Bites and Stings | 1 | 2023 | 39 | 0.200 |
Why?
|
| Immunocompromised Host | 1 | 2025 | 313 | 0.190 |
Why?
|
| Kidney Neoplasms | 1 | 2025 | 446 | 0.170 |
Why?
|
| Urticaria | 1 | 2021 | 20 | 0.170 |
Why?
|
| Metabolism, Inborn Errors | 1 | 2021 | 125 | 0.160 |
Why?
|
| Comparative Effectiveness Research | 1 | 2017 | 72 | 0.130 |
Why?
|
| Administration, Topical | 1 | 2017 | 131 | 0.130 |
Why?
|
| Humans | 10 | 2025 | 130931 | 0.130 |
Why?
|
| Remission Induction | 1 | 2017 | 306 | 0.120 |
Why?
|
| Infant | 3 | 2023 | 13210 | 0.120 |
Why?
|
| Child, Preschool | 3 | 2023 | 14945 | 0.110 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 1249 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2025 | 6862 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1302 | 0.100 |
Why?
|
| Female | 5 | 2025 | 70755 | 0.100 |
Why?
|
| Breast Neoplasms | 1 | 2025 | 2636 | 0.100 |
Why?
|
| Logistic Models | 1 | 2017 | 1822 | 0.090 |
Why?
|
| Adolescent | 3 | 2021 | 20814 | 0.090 |
Why?
|
| Male | 4 | 2025 | 64823 | 0.090 |
Why?
|
| Mutation | 1 | 2025 | 6144 | 0.090 |
Why?
|
| Prognosis | 1 | 2020 | 4930 | 0.080 |
Why?
|
| Phenotype | 1 | 2020 | 4493 | 0.080 |
Why?
|
| Child | 2 | 2020 | 26098 | 0.070 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 5257 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2025 | 1616 | 0.070 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2025 | 107 | 0.060 |
Why?
|
| Middle Aged | 1 | 2025 | 28735 | 0.060 |
Why?
|
| Young Adult | 1 | 2017 | 10040 | 0.050 |
Why?
|
| Cetirizine | 1 | 2021 | 4 | 0.040 |
Why?
|
| Mastocytosis | 1 | 2021 | 7 | 0.040 |
Why?
|
| Treatment Outcome | 1 | 2017 | 12858 | 0.040 |
Why?
|
| Anti-Allergic Agents | 1 | 2021 | 29 | 0.040 |
Why?
|
| Twins, Monozygotic | 1 | 2021 | 125 | 0.040 |
Why?
|
| Environment | 1 | 2021 | 149 | 0.040 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2021 | 222 | 0.040 |
Why?
|
| Metabolic Diseases | 1 | 2021 | 136 | 0.040 |
Why?
|
| Malnutrition | 1 | 2021 | 156 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2017 | 17485 | 0.040 |
Why?
|
| Wounds and Injuries | 1 | 2021 | 393 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 21134 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 3397 | 0.020 |
Why?
|
| HIV Infections | 1 | 2021 | 2031 | 0.020 |
Why?
|
| Neoplasms | 1 | 2021 | 2955 | 0.020 |
Why?
|
| Animals | 1 | 2023 | 34278 | 0.010 |
Why?
|